The Lauder Family Pledges $200M to Their Alzheimer’s Research Work
The Lauder family, one of America’s wealthiest families, has pledged $200M to their Alzheimer’s research work, setting a new benchmark in the fight against the debilitating disease.
This generous donation will help fund research, increase public awareness, and develop new therapies and treatments for Alzheimer’s disease.
The Lauder family has a personal connection to Alzheimer’s disease, with family matriarch Evelyn Lauder having suffered from the disease before her passing in 2011. Since then, the family has been committed to finding a cure and has invested heavily in research.
The new donation will go towards the Alzheimer’s Drug Discovery Foundation (ADDF), a nonprofit organization that supports research for the prevention and treatment of Alzheimer’s disease.
The ADDF is known for its innovative approach to research, focusing on developing drugs that can slow or stop the progression of Alzheimer’s disease.
The $200M donation is the largest ever received by the ADDF, and it will allow the organization to expand its efforts to find effective treatments for Alzheimer’s disease.
The donation will also help fund clinical trials and research projects, as well as provide funding for early-stage drug development.
The Lauder family has a long history of philanthropy and has donated generously to medical research in the past. They are committed to finding a cure for Alzheimer’s disease and hope that their donation will inspire others to give to this important cause.